Skip to main content

Alpha Teknova, Inc.

TKNO
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001850902

No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Alpha Teknova, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of TKNO: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders4431−13
Shares5.52M4.48M−1.04M (−18.9%)
Value$16.3M$12.0M−$4.32M (−26.5%)

New holders (5)

Institutions that held Alpha Teknova, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to TKNO in Q2 2023
InstitutionSharesValue% of portfolio
Y-Intercept (Hong Kong) Ltd44,757$119.5K0.01%
Old Mission Capital LLC15,484$41.3K0.00%
Brown Advisory Inc11,133$29.7K0.00%
Qube Research & Technologies Ltd10,137$27.1K0.00%
Rhumbline Advisers1,898$5.07K0.00%

Sold out (18)

Institutions that held Alpha Teknova, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.